Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”


August 9, 2021

Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman


July 7, 2021

Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting


June 30, 2021

Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT


June 28, 2021

Cardiol Therapeutics Closes $22 Million Bought Deal Offering


May 12, 2021

Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering


May 6, 2021

Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering


May 5, 2021

Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19


April 28, 2021

Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™


April 12, 2021

2024 Cardiol Therapeutics. All right reserved.